Atelvia™ (
risedronate delayed-release) is a prescription medication approved for treating
osteoporosis in postmenopausal women. It comes in a unique delayed-release tablet that eliminates the need to wait to eat or drink until 30 minutes after taking the tablet, unlike other medications in its class. In fact, Atelvia is designed to be taken right after breakfast.
Atelvia is made by Norwich Pharmaceuticals, Inc., for Warner Chilcott Pharmaceuticals, Inc.
Atelvia belongs to a group of medications known as bisphosphonates. The drug binds to certain cells in bones and slows down the rate at which bone breaks down. Atelvia tablets have a special coating that prevents them from dissolving until they reach the small intestine, where the medication can be absorbed, in order to prevent interactions with food.
The tablets also have a chelating agent, presumably to help reduce the interaction between Atelvia and metal ions such as
calcium or iron, although it is still recommended that calcium and iron be taken at different times of the day.
HealthSavvy Sign In
|
